Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Procter & Gamble Co Reaffirms Q2, FY 2013 Guidance


Thursday, 15 Nov 2012 09:00am EST 

Procter & Gamble Co announced that for the second quarter 2013, it estimating organic sales growth in the range of 1% to 3%, foreign exchange is expected to reduce sales by 2%, resulting in all-in sales guidance in the range of down 1% to up 1%, core EPS in the range of $1.07-$1.13, On an all-in basis, EPS in the range of $1.18-$1.25. For fiscal 2013, it expects organic sales growth guidance in the range of 2% to 4%, all-in net sales growth of in-line to up 1%, core earnings per share (EPS) in the range of $3.80-$4.00 and all-in GAAP EPS to a range of $3.78-$4.02. The Company reported revenue of $22.135 billion in the second quarter of 2012. The Company reported revenue of $83.7 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $21.836 billion and EPS of $1.11 for the second quarter of 2013; revenues of $84.20 billion and EPS of $3.96 for fiscal 2013.